BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 31405929)

  • 1. Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies.
    Muslimov IA; Iacoangeli A; Eom T; Ruiz A; Lee M; Stephenson S; Ginzler EM; Tiedge H
    J Neurosci; 2019 Sep; 39(39):7759-7777. PubMed ID: 31405929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune RNA dysregulation and seizures: therapeutic prospects in neuropsychiatric lupus.
    Muslimov IA; Berardi V; Stephenson S; Ginzler EM; Hanly JG; Tiedge H
    Life Sci Alliance; 2022 Oct; 5(12):. PubMed ID: 36229064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
    Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
    Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
    Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.
    Schett G; Dumortier H; Hoefler E; Muller S; Steiner G
    Ann Rheum Dis; 2009 May; 68(5):729-35. PubMed ID: 18495733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.
    Hassfeld W; Steiner G; Studnicka-Benke A; Skriner K; Graninger W; Fischer I; Smolen JS
    Arthritis Rheum; 1995 Jun; 38(6):777-85. PubMed ID: 7779120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.
    Becker Y; Marcoux G; Allaeys I; Julien AS; Loignon RC; Benk-Fortin H; Rollet-Labelle E; Rauch J; Fortin PR; Boilard E
    Front Immunol; 2019; 10():1026. PubMed ID: 31134086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins--a link between RA, SLE and MCTD.
    Steiner G; Skriner K; Hassfeld W; Smolen JS
    Mol Biol Rep; 1996; 23(3-4):167-71. PubMed ID: 9112225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases.
    Steiner G; Skriner K; Smolen JS
    Int Arch Allergy Immunol; 1996 Dec; 111(4):314-9. PubMed ID: 8957102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of autoantibodies associated with systemic lupus erythematosus.
    Lim Y; Lee DY; Lee S; Park SY; Kim J; Cho B; Lee H; Kim HY; Lee E; Song YW; Jeoung DI
    Biochem Biophys Res Commun; 2002 Jul; 295(1):119-24. PubMed ID: 12083777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for multiple shared antigenic determinants within Ro60 and other lupus-related ribonucleoprotein autoantigens in human autoimmune responses.
    Pal R; Deshmukh US; Ohyama Y; Fang Q; Kannapell CC; Gaskin F; Fu SM
    J Immunol; 2005 Dec; 175(11):7669-77. PubMed ID: 16301677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
    Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
    Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.
    Yaniv G; Twig G; Shor DB; Furer A; Sherer Y; Mozes O; Komisar O; Slonimsky E; Klang E; Lotan E; Welt M; Marai I; Shina A; Amital H; Shoenfeld Y
    Autoimmun Rev; 2015 Jan; 14(1):75-9. PubMed ID: 25449682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.
    Kowal C; Degiorgio LA; Lee JY; Edgar MA; Huerta PT; Volpe BT; Diamond B
    Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19854-9. PubMed ID: 17170137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-class a scavenger receptor autoantibodies from systemic lupus erythematosus patients impair phagocytic clearance of apoptotic cells by macrophages in vitro.
    Chen XW; Shen Y; Sun CY; Wu FX; Chen Y; Yang CD
    Arthritis Res Ther; 2011 Jan; 13(1):R9. PubMed ID: 21281474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Cocco C; Manca E; Corda G; Angioni MM; Noli B; Congia M; Loy F; Isola M; Chessa E; Floris A; Lorefice L; Saba L; Mathieu A; Ferri GL; Cauli A; Piga M
    Front Immunol; 2023; 14():1157149. PubMed ID: 37383228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein.
    Satoh M; Langdon JJ; Hamilton KJ; Richards HB; Panka D; Eisenberg RA; Reeves WH
    J Clin Invest; 1996 Jun; 97(11):2619-26. PubMed ID: 8647956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoprotein autoantibodies in lupus erythematosus.
    Provost TT; Herrera-Esparza R; Diaz LA
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):133s-139s. PubMed ID: 2409181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.